Luteolin antagonises human 5-HT3A receptor function through a non-competitive and voltage-independent mechanism

Inside the human body, a constant stream of chemical messages keeps the brain and nerves talking to one another. One of the most important messengers is a molecule called serotonin, which helps regulate mood, digestion, and the sensation of nausea. To receive these messages, cells use tiny protein gates on their surfaces that open and close like doors. When serotonin arrives, it pushes these doors open, allowing electricity to flow through the cell and trigger a response. Among these gates, a specific type known as the 5-HT3A receptor is unique because it acts as a direct switch for fast signals. These receptors are vital for controlling the urge to vomit and for sending sensory information from the gut to the brain, making them a primary target for medicines that treat chemotherapy-induced sickness and digestive disorders. While scientists have long studied how synthetic drugs interact with these gates, the way natural plant compounds might influence them has remained largely a mystery.

A team of researchers at Chonnam National University and Dongshin University in South Korea set out to investigate whether luteolin, a common natural compound found in vegetables, fruits, and herbs, could directly affect these serotonin gates. Luteolin is known for its broad health benefits, including anti-inflammatory and antioxidant properties, but its direct action on nerve cell channels was not well understood. The scientists wanted to see if this plant chemical could block the receptor's ability to open, and if so, how it managed to do it. To find the answer, they turned to a classic laboratory method that allows for precise observation of electrical activity in living cells. They grew frog eggs in the lab and injected them with the genetic instructions to build human 5-HT3A receptors on their surfaces. Once the eggs were ready, the researchers applied serotonin to see the electrical current flow, and then introduced luteolin to see what happened.

The results were clear and immediate. When the researchers added luteolin to the mixture, the electrical current generated by serotonin dropped significantly. The compound did not activate the gate on its own; instead, it acted as a powerful brake, stopping the receptor from opening even when serotonin was present. The inhibition was strong, with the researchers finding that a concentration of just 6.9 micromolar of luteolin was enough to cut the receptor's activity in half. This effect was reversible, meaning that when the luteolin was washed away, the receptors returned to normal function, suggesting a temporary and non-destructive interaction.

To understand exactly how luteolin worked, the team looked at whether it behaved like a typical drug that competes for the same spot as serotonin, or if it used a different strategy. They tested the receptor at different electrical voltages and found that luteolin's blocking power did not change, regardless of the electrical charge across the cell membrane. This ruled out the idea that luteolin was simply plugging the hole in the middle of the channel like a cork. Furthermore, when they increased the amount of serotonin, they could not overcome the blockage caused by luteolin. This indicated that luteolin was not fighting serotonin for the same entry point. Instead, it appeared to bind to a different location on the receptor, changing the shape of the gate in a way that prevented it from opening efficiently, no matter how much serotonin was present. This type of action is known as non-competitive inhibition.

To pinpoint the exact location where luteolin latched onto the receptor, the researchers combined computer modeling with genetic engineering. They used a digital simulation to predict where the luteolin molecule would fit best on the receptor's surface. The computer suggested that luteolin settled into a pocket near the top of the receptor, where two specific building blocks, or amino acids, named I66 and W178, were located. To prove this, the scientists created mutant versions of the receptor where they swapped out these specific building blocks for others. When they tested these modified receptors, they found that changing I66 or W178 made the receptor much less sensitive to luteolin. In fact, when both were changed, the receptor's ability to be blocked by luteolin was almost completely lost. This confirmed that these two specific parts of the protein are essential for luteolin to do its job.

The study concludes that luteolin is a potent and specific inhibitor of the human 5-HT3A receptor. It works by binding to a specific site on the outside of the receptor, involving the amino acids I66 and W178, and preventing the channel from opening without competing directly with serotonin. This discovery identifies a new molecular target for a well-known plant compound and suggests that natural flavonoids like luteolin can directly influence the electrical signaling of the nervous system. While the research was conducted in a controlled laboratory setting and does not yet confirm how this plays out in the human body, it provides a clear structural explanation for how a natural substance can modulate a critical biological switch involved in nausea and gut sensation.